Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial
Titel:
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial
Auteur:
Ahmed, Firas S. Dercle, Laurent Goldmacher, Gregory V. Yang, Hao Connors, Dana Tang, Ying Karovic, Sanja Zhao, Binsheng Carvajal, Richard D. Robert, Caroline Maitland, Michael L. Oxnard, Geoffrey R. Schwartz, Lawrence H.